SCTIMST transfers 5 medical device technologies to industry, including DBS system, electrodes, plasma fractionation, and wound dressings.

A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous ...

Circulate Health, the company dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan, today announces the publication of a single blind, ...

Octapharma has released the results from its prospective, randomized, double-blind, parallel group, crossover, placebo-controlled phase 3 study comparing the effectiveness of PANZYGA® (immune globulin ...

The duration of the interference with the immune response to the vaccine is related to the amount of antibody in the Ig preparation or blood product ... for the interval between administration of ...

Intravenous immunoglobulin (IVIG ... The onset of transaminitis is thought to be a result of maltose-containing stabilizing agents in IVIG preparation. Amino acids can also be used as stabilizing ...

Intravenous immunoglobulin therapy was associated with a later gestational age at birth and improved chances of survival. A new systematic review and analysis has determined that maternal intravenous ...

GC Biopharma USA's rigorous studies have confirmed that a novel 10% IVIG manufacturing process, including CEX chromatography, is a reliable means of removing FXIa from the final preparation.

TEANECK, N.J., Dec. 5, 2023 /PRNewswire/ -- GC Biopharma USA announced that a manuscript describing its landmark CEX technology, which removes FXIa from its 10% intravenous immunoglobulin (IVIG) ...

Intravenous immunoglobulin (IVIG) therapy is safe and effective in ... It is recognized that the preparation “inhibits cytokine-dependent T-cell activation and the complement pathway, blocks the Fc ...